MYHEP LVIR is a fixed-dose combination of "Ledipasvir and Sofosbuvir" which are direct acting antiviral agents against the hepatitis C virus (HCV). Ledipasvir is an inhibitor of the protein, which is required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridineanalog triphosphate which can be incorporated into HCV RNA and acts as a chain terminator.
MYHEP LVIR is used for the treatment of chronic hepatitis C virus (HCV).
- MYHEP LVIR is a prescription drug and should be used under proper medical guidance and advice.
- MYHEP LVIR is contradicted for use when taken with other medications to treat Tuberculosis, Seizures, HIV, Cancer, Cholesterol, Heart ailments and other anti-viral medications.
90 mg Ledipasvir / 400 mg Sofosbuvir
1*28 Tablets (Bottle)
Store at a Temperature not exceeding 30 C